Skip to main content

Table 1 Demographic data (n = 40 patients)

From: Dexmedetomidine is effective and safe during NIV in infants and young children with acute respiratory failure

Variables

Median (IQR)

Age (months)

16 (6,50-33,50)

Weight (kg)

12 (6,2–17)

Gender (M/F)

30/10

PRSIM III 24

15,50 (12–22)

Niv Duration (hours)

48 (36;96)

PICU LOS (days)

7 (5–18,7)

PO2/FiO2 Ratio at NIV onset

175 (150–203)

Main diagnosis

 Bronchiolitis

12 (30%)

 ARDS

7 (17,5%)

 Chest trauma

2 (5%)

 Burn-associated Respiratory Failure

4 (10%)

 Status Asthmaticus

3 (7,5%)

 Neurological illness

3 (7,5%)

 Pneumonia

4 (10%)

 Bronchopulmonary Dysplasia

3 (7,5%)

 Post-operative patients

2 (5%)

NIV Interfaces

 Helmet

12 (30%)

 Total Face Mask

11 (27,5%)

 Nasal Mask

17 (42,5%)

  1. NIV Non Invasive Ventilation, PICU LOS Pediatric intensive Critical Unit length of stay, ARDS acute respiratory distress syndrome